Same protocol, same duration, same titration rules, 751 adults randomized 1:1
A higher percentage of patients treated with tirzepatide achieved an HbA1c level below 7% compared to those treated with the placebo

Specialty Pharmacy Clinical Policy Bulletins, Aetna Non-Medicare Prescription Drug Plan, Subject: Weight Loss (BMI 35) GIP-GLP-1, GLP-1 Agonists PA with Limit 6450-C P08-2025 v8, Aetna (2026) Medicare GLP-1 Bridge, Centers for Medicare & Medicaid Services (2026) 2026 Aetna Pharmacy Drug Guide, High Value Plan, Aetna (2026) 2026 Aetna Pharmacy Drug Guide, Advanced Control Choice Plan, Aetna (2026) 2026 Aetna Pharmacy Drug Guide, Standard Opt Out Plan, Aetna (2026) 2026 Aetna Pharmacy Drug Guide, Advanced Control Plan Aetna Kentucky, Aetna (2026) 2026 Aetna Pharmacy Drug Guide, Basic Control Plan, Aetna (2026) 2026 Aetna Pharmacy Drug Guide, Standard Control Plan, Aetna (2026) 2026 Aetna Pharmacy Drug Guide, Standard Control Choice Plan, Aetna (2026) Aetna Better Health of Oklahoma Formulary Guide, Aetna (2026) Florida Medicaid Preferred Drug List, Florida Agency for Health Care Administration (2026) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

Together, this dual-action approach provides a comprehensive way to support metabolic health
Risk of suicide attempt and suicide death following completion of the Patient Health Questionnaire depression module in community practice
That constant monitoring drives faster results